1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PTPN11 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA NPSR1 CTRPv2 pan-cancer AAC 0.086 0.01
mRNA CDC123 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA OR6C70 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA ISM1 CTRPv2 pan-cancer AAC 0.086 0.01
mRNA MEGF10 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA PIP5K1B CTRPv2 pan-cancer AAC 0.096 0.01
mRNA TUBB CTRPv2 pan-cancer AAC -0.095 0.01
mRNA C1QA CTRPv2 pan-cancer AAC 0.084 0.01
mRNA CUL5 CTRPv2 pan-cancer AAC -0.086 0.01
Download CSV